Morgan, Lewis & Bockius acted as legal counsel to Eli Lilly, and Ropes & Gray acted as legal counsel to Sigilon. Eli Lilly and Company (NYSE:...
Eli Lilly’s Acquisition of Sigilon Therapeutics
Goldfinch Bio’s Exclusive Global License Agreement with Karuna Therapeutics
Ropes & Gray represented Goldfinch Bio on the deal. Goldfinch Bio announced an exclusive global license agreement with Karuna Therapeutics under which Karuna will have development, manufacturing...
HUTCHMED’s License Agreement with Takeda Pharmaceutical
Ropes & Gray represented HUTCHMED on the deal. HUTCHMED (China) Limited and its subsidiary, HUTCHMED Limited announced an exclusive worldwide license agreement with Japan’s largest drugmaker Takeda...
Scipher Medicine’s Acquisition of CrossBridge
Ropes & Gray represented Scipher Medicine on the deal. Precision immunology company Scipher Medicine announced its acquisition of data, analytics and software company CrossBridge to enhance...
Patient Square Capital and Gurnet Point Capital’s $890 Million Acquisition of Radius Health
Kirkland & Ellis advised Patient Square Capital, Ropes & Gray advised Radius, Latham & Watkins advised Gurnet Point Capital, Covington & Burling served as OrbiMed’s legal...
National Resilience’s $110 Million Alliance with Bluebird Bio to Develop Cell Therapies
Ropes & Gray advised National Resilience on the deal. National Resilience, Inc., a biopharmaceutical manufacturing specialist, closed a strategic alliance with bluebird bio, Inc., to accelerate...
Merck’s $11.5 Billion Acquisition of Acceleron Pharma
Covington & Burling and Gibson, Dunn & Crutcher advised Merck, while Ropes & Gray advised Acceleron. Skadden, Arps, Slate, Meagher & Flom represented Centerview Partners LLC...